Eptifibatide Acetate CAS 148031-34-9 (Free Base) Purity >98.0% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of Eptifibatide Acetate (CAS: 148031-34-9) with high quality. Ruifu Chemical can provide worldwide delivery, competitive price, excellent service, small and bulk quantities available. Purchase Eptifibatide Acetate, Please contact: alvin@ruifuchem.com
Chemical Name | Eptifibatide Acetate |
Sequence | Map-Har-Gly-Asp-Trp-Pro-Cys-NH2 (Map-Cys); Mpr-Harg-Gly-Asp-Trp-Pro-Cys-NH2, ( Disulfide Bridge:1-7); Mpr-Harg-Gly-Asp-Trp-Pro-Cys-NH2, ( Disulfide Bridg on Mpr and Cys); Integrilin |
Stock Status | In Stock, Commercial Production |
CAS Number | 148031-34-9 (Free Base) |
Related CAS | 881997-86-0 |
Molecular Formula | C35H49N11O9S2 |
Molecular Weight | 831.962 g/mol |
Melting Point | >220℃(dec.) |
Density | 1.62g/cm3 |
Refractive Index n20/D | 1.742 |
Storage Temp. | Store in Freezer, Under -20℃ |
COA & MSDS | Available |
Origin | Shanghai, China |
Expiration Date | 12 Months From Date of Receipt |
Brand | Ruifu Chemical |
Items | Specifications | Results |
Appearance | White to Off-White Powder | Complies |
Peptide Purity / Analysis Method | >98.0% (HPLC, by Area Integration) | 98.57% |
Related Substance (By HPLC) | ||
Total Impurities | <2.00% | Complies |
Largest Single Impurity | <1.00% | Complies |
Infrared Spectrum | Consistent with Structure | Complies |
NMR Spectrum | Consistent with Structure | Complies |
MS Spectrum | Consistent with Structure | Complies |
Conclusion | The product has been tested and complies with the given specifications | |
Note | For Research Use Only, Not for Human Use |
Package: Plastic vial (dedicated for peptide packing) or glass vial, quantity according to customer's requirement.
Storage Condition: Keep the vial tightly closed and store in a cool, dry and well-ventilated warehouse, store in freezer, under -20℃, away from incompatible substances. Protect from light and moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery.
How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.
Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.
Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.
Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.
Factory Audit? Factory audit welcome. Please make an appointment in advance.
MOQ? No MOQ. Small order is acceptable.
Delivery Time? If within stock, three days delivery guaranteed.
Transportation? By Express (FedEx, DHL), by Air, by Sea.
Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.
Custom Synthesis? Can provide custom synthesis services to best fit your research needs.
Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Eptifibatide Acetate (CAS: 148031-34-9), an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class, is a cyclic heptapeptide constructed from 6 amino acids and a mercaptopropionyl residue. Eptifibatide is used to treat acute coronary syndrome. American College of Cardiology (ACC) and the American Heart Association (AHA) guidelines recommend eptifibatide injection can be used for acute coronary syndrome (unstable angina, non-ST-segment elevation myocardial infarction) or supporting through percutaneous coronary intervention (PCI) drug treatment , it is continuous used for 72 hours.
Eptifibatide Acetate (CAS: 148031-34-9), the Eptifibatide peptide is produced by solution-phase peptide synthesis, and is purified by preparative reverse-phase liquid chromatography and lyophilized.